Hematology & Oncology Doctors in Antioch, CA Accepting Medicare

5 Hematology & Oncology doctors found. Showing 1 - 5

Prasad Pillai, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4721 Dallas Ranch Rd, Antioch, CA 94531 Phone: 925-778-0679    Fax: 925-778-3567

Jiyon Jane Choi, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4721 Dallas Ranch Rd, Antioch, CA 94531 Phone: 925-778-0679    Fax: 925-778-3567

Dr. John T Ganey, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4721 Dallas Ranch Road, Antioch, CA 94531 Phone: 925-778-0679    Fax: 925-778-3567

Wilson Tong, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4721 Dallas Ranch Rd, Antioch, CA 94531 Phone: 925-778-0679    Fax: 925-778-3567

Dr. Bimal J Patel, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4721 Dallas Ranch Road, Antioch, CA 94531 Phone: 925-778-0679    Fax: 925-778-3567

News Archive

Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19

A multinational research group recently published a paper in the journal Lancet Respiratory Medicine which describes the first patient with a severe form of coronavirus disease (COVID-19) that was successfully treated with human recombinant soluble ACE2.

Study reveals that nondrinkers have higher mortality risk than light drinkers

As a class, people who don't drink at all have a higher mortality risk than light drinkers. But nondrinkers are a diverse bunch, and the reasons people have for abstaining affects their individual mortality risk, in some cases lowering it on par with the risk for light drinkers, according to a University of Colorado study.

AB SCIEX launches IVD-MS Analyzer CE marked for general in vitro diagnostic use in Europe

Continuing to rapidly expand its presence in the clinical diagnostics field, AB SCIEX, a global leader in analytical technologies, today announced the launch of its AB SCIEX IVD-MS™ Analyzer CE marked for general in vitro diagnostic use in Europe.*

QLT board approves increase in share repurchase program

QLT Inc. today announced that, subject to regulatory approval, the Board of Directors has approved an increase in the number of common shares that QLT may purchase under its normal course issuer bid over the twelve month period that commenced on November 3, 2009, from 2,731,534 common shares, representing 5% of the outstanding common shares on October 28, 2009, to 4,700,060 common shares, representing 10% of the public float as at that date.

New QUANTEC guidelines for safe treatment of cancer with radiation therapy

The culmination of a two-year effort to review available studies and establish new guidelines for the safe treatment of cancer with radiation therapy was published today in the International Journal of Radiation Oncology, Biology and Physics.

Read more Medical News

› Verified 1 days ago